Induction of Therapeutic Antitumor Immunity by In Vivo Administration of a Lentiviral Vaccine

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Human Gene Therapy

• Publication date

  2005-10-31

• Fields of study

  Medicine

• Identifiers
  DOI 10.1089/hum.2005.16.1255PMID 16259559
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oncogenesis following delivery of a nonprimate lentiviral gene therapy vector to fetal and neonatal mice.

  2005cited by this paper
• ‘Survival gene’ Bcl-xl potentiates DNA-raised antitumor immunity

  2005cited by this paper
• Enhanced immunity by NeuEDhsp70 DNA vaccine Is needed to combat an aggressive spontaneous metastatic breast cancer.

  2005cited by this paper
• Dendritic cell immunotherapy: mapping the way

  2004cited by this paper
• Secretory heat-shock protein as a dendritic cell-targeting molecule: a new strategy to enhance the potency of genetic vaccines

  2004cited by this paper
• Intravenous Injection of a Lentiviral Vector Encoding NY-ESO-1 Induces an Effective CTL Response1

  2004influential reference
• T cell repertoire scanning is promoted by dynamic dendritic cell behavior and random T cell motility in the lymph node.

  2004cited by this paper
• Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo.

  2003cited by this paper
• Immunotherapeutic targeting of shared melanoma-associated antigens in a murine glioma model.

  2003cited by this paper
• Cancer vaccines: between the idea and the reality

  2003cited by this paper
• Lentivirally transduced dendritic cells as a tool for cancer immunotherapy

  2003cited by this paper
• In vivo administration of a lentiviral vaccine targets DCs and induces efficient CD8(+) T cell responses.

  2003cited by this paper
• Facets of heat shock protein 70 show immunotherapeutic potential

  2003cited by this paper
• LAG-3 enables DNA vaccination to persistently prevent mammary carcinogenesis in HER-2/neu transgenic BALB/c mice.

  2003cited by this paper
• Hsp70 promotes antigen-presenting cell function and converts T-cell tolerance to autoimmunity in vivo

  2003cited by this paper
• A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency.

  2003cited by this paper
• Dynamics of CD8+ T cell priming by dendritic cells in intact lymph nodes

  2003cited by this paper
• Germline Transmission and Tissue-Specific Expression of Transgenes Delivered by Lentiviral Vectors

  2002influential reference
• Exploiting dendritic cells to improve vaccine efficacy.

  2002cited by this paper
• Enhancement of antitumor immunity by prolonging antigen presentation on dendritic cells

  2002influential reference
• Vaccines: Spinning molecular immunology into successful immunotherapy

  2002influential reference
• Use of a lentiviral flap vector for induction of CTL immunity against melanoma. Perspectives for immunotherapy

  2002cited by this paper
• Cancer vaccines: progress reveals new complexities.

  2002influential reference
• Efficient Transduction of Dendritic Cells and Induction of a T-Cell Response by Third-Generation Lentivectors

  2002influential reference
• Lentiviral vectors containing the human immunodeficiency virus type-1 central polypurine tract can efficiently transduce nondividing hepatocytes and antigen-presenting cells in vivo.

  2002cited by this paper
• Immunity against cancer: lessons learned from melanoma.

  2001cited by this paper
• Targeting dendritic cells to enhance DNA vaccine potency.

  2001cited by this paper
• Progress in human tumour immunology and immunotherapy

  2001cited by this paper
• Dendritic cells as vectors for therapy.

  2001cited by this paper
• Lentiviral Vector-Mediated Tyrosinase-Related Protein 2 Gene Transfer to Dendritic Cells for the Therapy of Melanoma

  2001cited by this paper
• Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen

  2001cited by this paper
• Relevance of the Tumor Antigen in the Validation of Three Vaccination Strategies for Melanoma1

  2000cited by this paper
• Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene.

  2000cited by this paper
• Lentiviral vectors: excellent tools for experimental gene transfer and promising candidates for gene therapy

  2000cited by this paper
• DNA vaccines: immunology, application, and optimization*.

  2000influential reference
• Development of a Self-Inactivating Lentivirus Vector

  1998cited by this paper
• Induction of antigen-specific T cell anergy: An early event in the course of tumor progression.

  1998cited by this paper
• Self-Inactivating Lentivirus Vector for Safe and Efficient In Vivo Gene Delivery

  1998cited by this paper
• Identification of Tyrosinase-related Protein 2 as a Tumor Rejection Antigen for the B16 Melanoma

  1997cited by this paper
• Human tumor antigens recognized by T lymphocytes

  1996cited by this paper
• The neu oncogene encodes an epidermal growth factor receptor-related protein

  1986cited by this paper
• Conserved features of eukaryotic hsp70 genes revealed by comparison with the nucleotide sequence of human hsp70.

  1985cited by this paper

• Diversity of extracellular HSP70 in cancer: advancing from a molecular biomarker to a novel therapeutic target

  2024cites this paper
• HSP70 Family in Cancer: Signaling Mechanisms and Therapeutic Advances

  2023cites this paper
• Lentiviral Vectors as a Vaccine Platform against Infectious Diseases

  2023cites this paper
• Use of lentiviral vectors in vaccination

  2021cites this paper
• The Journey of in vivo Virus Engineered Dendritic Cells From Bench to Bedside: A Bumpy Road

  2018cites this paper
• Viral gene therapy for breast cancer: progress and challenges

  2017cites this paper
• Genetic Vaccines To Potentiate the Effective CD103+ Dendritic Cell–Mediated Cross-Priming of Antitumor Immunity

  2015cites this paper
• Dendritic cell-derived interleukin-15 is crucial for therapeutic cancer vaccine potency

  2014cites this paper
• Chapter 24 – Lentivector Vaccines

  2014cites this paper
• Lentiviral vector vaccines for T cell-mediated protection against influenza

  2014cites this paper
• Lentiviral vectors: a versatile tool to fight cancer.

  2013cites this paper
• HER2/neu-specific Breast Cancer Vaccine

  2013cites this paper
• Dendritic Cells and Lentiviral Vectors: Mapping the Way to Successful Immunotherapy

  2012influential citation
• Lentivector based gene transfer for immunotherapy – application of integration deficient vectors and PDL1knockdown as tools to manipulate immune responses

  2012cites this paper
• Immunomodulation by Genetic Modification Using Lentiviral Vectors

  2012cites this paper
• Genetic targeting of the active transcription factor XBP1s to dendritic cells potentiates vaccine-induced prophylactic and therapeutic antitumor immunity.

  2012cites this paper
• Immunization delivered by lentiviral vectors for cancer and infectious diseases

  2011cites this paper
• Dendritic cell-directed lentivector vaccine induces antigen-specific immune responses against murine melanoma

  2011cites this paper
• Dendritic Cells and Lentiviral Vectors: Mapping the Way to Successful Immuno Gene Therapy

  2011cites this paper
• Targeting lentiviral vectors for cancer immunotherapy.

  2011cites this paper
• Vaccines delivered by integration-deficient lentiviral vectors targeting dendritic cells induces strong antigen-specific immunity.

  2010cites this paper
• The Treatment and Prevention of Mouse Melanoma With an Oral DNA Vaccine Carried by Attenuated Salmonella Typhimurium

  2010cites this paper
• Emerging applications of lentiviral vectors in dendritic cell-based immunotherapy.

  2010cites this paper
• A strategy of tumor treatment in mice with doxorubicin-cyclophosphamide combination based on dendritic cell activation by human double-stranded DNA preparation

  2010cites this paper
• HIV-1 Lentiviral Vector Immunogenicity Is Mediated by Toll-Like Receptor 3 (TLR3) and TLR7

  2010cites this paper
• Monocytes transduced with lentiviral vectors expressing hepatitis C virus non-structural proteins and differentiated into dendritic cells stimulate multi-antigenic CD8(+) T cell responses.

  2010cites this paper
• Lentiviral vectors for immunization: an inflammatory field

  2010cites this paper
• Consequences of persistent antigen presentation following administration of HIV-1-derived lentiviral vectors

  2010cites this paper
• HIV-1 Gag-specific immunity induced by a lentivector-based vaccine directed to dendritic cells

  2009cites this paper
• Single-Chain Antibodies That Target Lentiviral Vectors to MHC Class II on Antigen-Presenting Cells

  2009cites this paper
• Nonintegrating Lentivector Vaccines Stimulate Prolonged T-Cell and Antibody Responses and Are Effective in Tumor Therapy

  2009cites this paper
• Potent induction of B- and T-cell immunity against human carcinoembryonic antigen-expressing tumors in human carcinoembryonic antigen transgenic mice mediated by direct lentivector injection

  2009cites this paper
• Nonintegrating Lentiviral Vectors Can Effectively Deliver Ovalbumin Antigen for Induction of Antitumor Immunity

  2009cites this paper
• Analysis of the Role of Tripeptidyl Peptidase II in MHC Class I Antigen Presentation In Vivo1

  2009cites this paper
• Dendritic cells for active anti-cancer immunotherapy: targeting activation pathways through genetic modification.

  2009cites this paper
• Vivo II in MHC Class I Antigen Presentation In Analysis of the Role of Tripeptidyl Peptidase Farfan

  2009cites this paper
• Npgrj_Nbt_1390 326..334

  2008cites this paper
• Lentiviral vectors for anti-tumor immunotherapy.

  2008cites this paper
• Expression of vFLIP in a Lentiviral Vaccine Vector Activates NF-κB, Matures Dendritic Cells, and Increases CD8+ T-Cell Responses

  2008cites this paper
• Engineered lentivector targeting of dendritic cells for in vivo immunization

  2008cites this paper
• Immunization with a Lentivector That Targets Tumor Antigen Expression to Dendritic Cells Induces Potent CD8 (cid:1) and CD4 (cid:1) T-Cell Responses (cid:1)

  2007cites this paper
• Recombinant lentivector as a genetic immunization vehicle for antitumor immunity

  2007cites this paper
• Lentiviral vectors for cancer immunotherapy: transforming infectious particles into therapeutics

  2007cites this paper
• Immunisation with a lentivector that targets tumour antigen expression to dendritic cells induces potent CD 8 + and CD 4 + T cell responses

  2007influential citation
• Immunization with a Lentivector That Targets Tumor Antigen Expression to Dendritic Cells Induces Potent CD8+ and CD4+ T-Cell Responses

  2007cites this paper
• Activation of Immature Monocyte-Derived Dendritic Cells After Transduction with High Doses of Lentiviral Vectors

  2007cites this paper
• Lentiviruses in cancer immunotherapy

  2007cites this paper
• Lentiviral vectors encoding HIV-1 polyepitopes induce broad CTL responses in vivo.

  2007cites this paper
• Lentivirus as a potent and mechanistically distinct vector for genetic immunization.

  2007cites this paper
• Evaluation of a Self-Inactivating Lentiviral Vector Expressing Simian Immunodeficiency Virus Gag for Induction of Specific Immune Responses in Vitro and in Vivo

  2006cites this paper
• Transgene Expression by a Large Fraction of Dendritic Cells Following Autologous Transplantation of Retrovirally Transduced CD34 Cells

  2006cites this paper
• Dendritic cell based cancer vaccines using adenovirally mediated expression of the HER-2/neu gene and apoptotic tumor cells expressing heat shock protein 70

  2006cites this paper
• Fusion protein of ATPase domain of Hsc70 with TRP2 acting as a tumor vaccine against B16 melanoma.

  2006cites this paper